Edition:
United Kingdom

Pluristem Therapeutics Inc (PSTI.OQ)

PSTI.OQ on NASDAQ Stock Exchange Capital Market

1.31USD
21 Sep 2018
Change (% chg)

$-0.02 (-1.50%)
Prev Close
$1.33
Open
$1.33
Day's High
$1.33
Day's Low
$1.30
Volume
16,343
Avg. Vol
63,266
52-wk High
$2.12
52-wk Low
$1.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.081
Mar '18 0.00 -0.014
Dec 0.05 -0.078
Sep 0.00 -0.076
FY 2017 Jun '17 0.00 -0.073
Mar '17 0.00 -0.086
Dec 0.00 -0.082
Sep 0.00 -0.078
FY 2016 Jun '16 0.00 -0.077
Mar '16 0.00 -0.090
Dec 2.75 -0.050
Sep 0.09 -0.075
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Quarter Ending Jun-18 4 0.00 0.00 0.00 --
Year Ending Jun-18 5 0.03 0.05 0.00 --
Year Ending Jun-19 4 0.79 3.15 0.00 13.05
Year Ending Jun-20 3 30.69 47.78 18.93 13.11
Earnings (per share)
Quarter Ending Mar-18 2 -0.09 -0.09 -0.09 --
Quarter Ending Jun-18 4 -0.07 -0.02 -0.09 --
Year Ending Jun-18 5 -0.23 -0.19 -0.26 --
Year Ending Jun-19 4 -0.37 -0.34 -0.39 -0.34
Year Ending Jun-20 3 -0.20 -0.07 -0.33 -0.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 0.11 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 4.77 15.51 5.00
Price to Tangible Book (MRQ) 4.80 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 4.54 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.53 8.01
Sales (TTM) vs TTM 1 Yr. Ago -100.00 80.36 5.63
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.61 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -9.12 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -23.89 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 5.36 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. 96.64 50.58 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -2,708.36 -600.62 10.68
Operating Margin (TTM) -- -759.72 4.32
Operating Margin - 5 Yr. Avg. -2,957.00 -621.65 6.11
Pre-Tax Margin (TTM) -- -733.57 5.18
Pre-Tax Margin - 5 Yr. Avg. -2,890.38 -627.35 6.51
Net Profit Margin (TTM) -- -734.94 1.48
Net Profit Margin - 5 Yr. Avg. -2,890.38 -630.39 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,228,954 860,374,110
Net Income/Employee (TTM) -158,937 3,144,136 101,207,069
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.64 -0.15 11.13
Return on Assets - 5 Yr. Avg. -41.42 3.51 12.40
Return on Investment (TTM) -76.96 1.78 14.61
Return on Investment - 5 Yr. Avg. -46.17 2.56 16.13
Return on Equity (TTM) -81.32 3.27 16.33
Return on Equity - 5 Yr. Avg. -49.55 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -8.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pluristem Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 27.35 22.96 99 52
13 Week 18.25 12.50 99 66
26 Week 1.36 -6.34 99 80
52 Week -4.08 -18.70 96 50
YTD 4.20 -8.49 98 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.55%
# of Holders: 38
Total Shares Held: 4,033,032
3 Mo. Net Change: -370,952
# New Positions: 5
# Closed Positions: 5
# Increased Positions: 21
# Reduced Positions: 11
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.